Biocomposites Takes Minority Stake in Renovos Biologics

Biocomposites Acquires Artoss GmbH (NanoBone technology)

June 6, 2023

Medical Devices

Biocomposites, the UK-based medical devices company, has acquired Artoss GmbH, a Rostock, Germany-based maker of NanoBone bone graft substitutes. The acquisition adds Artoss' proprietary NanoBone technology to Biocomposites' product portfolio and gives the technology access to Biocomposites' global distribution network.

Biocomposites Acquires Remaining Shares in Laboratorios SL S.A. and Synergie Ingénierie Médicale S.A.R.L.

September 18, 2024

Medical Devices

Biocomposites has acquired the remaining shares in Laboratorios SL S.A. and Synergie Ingénierie Médicale S.A.R.L., gaining full control of the SYNICEM™ and Subiton antibiotic bone cement and preformed spacer product ranges. The deal consolidates Biocomposites' capabilities in infection-management bone cements and spacers and will allow the company to leverage its global distribution network to expand these products' reach.

OmniActive Health Technologies Acquires ENovate Biolife

November 4, 2024

Food & Beverage

OmniActive Health Technologies has acquired ENovate Biolife to expand its portfolio of clinically validated botanical and specialty active ingredients for dietary supplements, functional foods and sports nutrition. The acquisition strengthens OmniActive's R&D, clinical and commercial capabilities and aims to accelerate global distribution of ENovate's ingredients such as Muvz, RedNite and Oxyjun.

1315 Capital Acquires Biocoat, Inc.

January 16, 2019

Medical Devices

Philadelphia-based healthcare investment firm 1315 Capital has acquired Biocoat, Inc., a Horsham, Pennsylvania specialty manufacturer of hydrophilic biomaterial coatings for medical devices; the transaction closed on December 20, 2018. 1315 Capital's investment will provide expansion and growth capital to accelerate R&D, expand Biocoat's operating model, and support broader commercial efforts across neurovascular, cardiovascular, peripheral, and ophthalmic end markets.

Novo Holdings Acquires Double-Digit Stake in bioMASON

December 17, 2019

Manufacturing

Novo Holdings A/S made a multimillion-dollar, double-digit equity investment in US-based bioMASON to help commercialize its bacteria-grown biocement masonry products. As part of the deal Anders Spohr of Novo Holdings will join bioMASON's board as the company scales its sustainable concrete alternative for construction and infrastructure markets.

Versalis Acquires Remaining 64% Stake in Novamont from Mater-Bi

April 28, 2023

Manufacturing

Versalis, Eni's chemical company, has signed an agreement to acquire the remaining 64% of Novamont held by Mater-Bi (controlled by Investitori Associati II and NB Renaissance), giving Versalis full ownership of Novamont. The deal aims to integrate Novamont's renewable-chemistry platform into Versalis to accelerate capability expansion and decarbonize Versalis' product portfolio; closing is subject to regulatory approvals.